alanylglutamine has been researched along with Chronic Kidney Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aufricht, C; Herzog, R; Kaufmann, M; König, F; Kratochwill, K; Lhotta, K; Machold-Fabrizii, V; Oberbauer, R; Probst, P; Ribitsch, W; Rosenkranz, AR; Salmhofer, H; Vychytil, A; Wiesholzer, M; Windpessl, M | 1 |
| Druml, W; Hübl, W; Lochs, H; Roth, E | 1 |
1 trial(s) available for alanylglutamine and Chronic Kidney Failure
| Article | Year |
|---|---|
A randomized controlled trial of alanyl-glutamine supplementation in peritoneal dialysis fluid to assess impact on biomarkers of peritoneal health.
Topics: Aged; Austria; Biomarkers; Cross-Over Studies; Dialysis Solutions; Dipeptides; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis; Peritoneum; Peritonitis; Proof of Concept Study; Prospective Studies; Treatment Outcome | 2018 |
1 other study(ies) available for alanylglutamine and Chronic Kidney Failure
| Article | Year |
|---|---|
Importance of liver and kidney for the utilization of glutamine-containing dipeptides in man.
Topics: Adult; Amino Acids; Dipeptides; Female; Glutamine; Humans; Kidney; Kidney Failure, Chronic; Liver; Liver Cirrhosis; Male; Middle Aged; Reference Values | 1994 |